
View larger version (20K):
[in a new window]
|
Fig. 1. MBSA-MDP-mediated killing of Salmonella in vitro and in vivo. (A)
J774E macrophages (1x106 cells/well) were treated with the
indicated concentrations of MBSA-MDP or free MDP for 12 hours. Treated
macrophages were infected with Salmonella typhimurium
(1x107) as described in the Materials and Methods, and the
infected cells were incubated in the respective drug-containing medium. After
incubation for 12 hours at 37°C, the macrophages were lysed in
solubilization buffer, and an aliquot of the cell lysates was used to
determine the level of viable bacteria they contain (colony-forming units).
Results are expressed as an average of three determinations±s.d. (B) To
determine the efficacy of MBSA-MDP for treatment of Salmonella
infection in vivo, C57B1-6 mice were infected with Salmonella as
described in the Materials and Methods on day 0. Subsequently,
Salmonella-infected animals received intraperitoneal injections of
free MDP or MBSA-MDP (1 µg/mouse of MDP equivalent; 50 µg/kg body
weight) or ciprofloxacin (1.4 mg/mouse; 70 mg/kg body weight) daily for four
consecutive days. Finally, the splenic load of Salmonella was
determined by measuring the colony forming units on day 10 as described in the
Materials and Methods. Results are expressed as percentage survival of three
independent experiments±s.e. The number of colonies in untreated
control mice (2.21x104 CFU±s.e.) was taken as
100%.
|